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Supplementary Table S3; Al-Qaoud et al, AJKD, “Socioeconomic Status and Reduced Kidney Function 
in the Whitehall II Study: Role of Obesity and Metabolic Syndrome” 
Table S3. Age and lean mass index (LMI) adjusted odds ratios (95% confidence intervals (CI)) 
by sex for the associations between decreased GFR (eGFR <60 ml/min/1.73m2 derived from 
IDMS calibrated CKD-EPI formula) and body-mass index (BMI), and components of the 
metabolic syndrome amongst sample with impedance measurements (each row refers to a 
separate model on the same set of participants)  
 Men (N=3627) Women (N=1211) 
Factor Odds ratio (95%CI) p-value Odds ratio (95%CI) p-value 





1.62(1.16 to 2.27) 





2.07(1.04 to 4.09) 









1.63(1.05 to 2.53) 
1.79(1.16 to 2.76) 






1.21(0.56 to 2.62) 
0.92(0.40 to 2.10) 










0.61(0.40 to 0.92) 
0.60(0.40 to 0.91) 






0.51(0.24 to 1.09) 
0.69(0.35 to 1.38) 










0.71(0.47 to 1.06) 
0.88(0.60 to 1.30) 






0.59(0.29 to 1.19) 
0.36(0.15 to 0.86) 










0.60(0.42 to 0.87) 
0.55(0.35 to 0.86) 






0.68(0.34 to 1.36) 
0.60(0.30 to 1.23) 










1.57(1.03 to 2.39) 
2.07(1.39 to 3.08) 






0.82(0.32 to 2.08) 
2.08(1.03 to 4.20) 










1.10(0.73 to 1.65) 
0.99(0.65 to 1.49) 






0.72(0.36 to 1.43) 
0.67(0.31 to 1.42) 





Diabetes prevalence  (yes vs. no) 1.75 (1.20 to 2.57) 0.004 0.74(0.32 to 1.72) 0.5 
*Sex specific quartiles of factors, OR demonstrate comparison to lowest quartile (Q1) 
**BMI OR demonstrate comparison to participants in underweight/normal category 
-Abbreviations: BMI: body mass index, BP: blood pressure, HDL: high density lipoprotein cholesterol. 
-Conversion factors: HDL cholesterol mg/dL to mmol/L, x 0.02586; Triglycerides mg/dL to mmol/L, x 
0.01129; Fasting glucose mg/dL to mmol/L, x 0.05551    
 
 
